Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12779/4212
DC FieldValueLanguage
dc.contributor.authorSavini, Luisaen_us
dc.contributor.authorMassarelli, Paolaen_us
dc.contributor.authorChiasserini, Luisaen_us
dc.contributor.authorNencini, Cristinaen_us
dc.contributor.authorPellerano, Cesareen_us
dc.date.accessioned2021-03-30T14:42:30Z-
dc.date.available2021-03-30T14:42:30Z-
dc.date.issued1997-
dc.identifier.issn0014-827Xen_US
dc.identifier.urihttp://hdl.handle.net/20.500.12779/4212-
dc.description20303en_US
dc.description.abstractA number of pyruvic acid and methylpyruvate alpha-(N)-heterocyclic hydrazones has been synthesized. Bis-heterocyclic hydrazones were obtained from reaction with pyruvic carboxaldehyde. Some complexes of Ni(II) were prepared and characterized as neutral complexes. All these compounds have been evaluated for cytotoxicity against P388 and HL-60 leukemia.en_US
dc.language.isoenen_US
dc.relationNoneen_US
dc.relation.ispartofIL FARMACOen_US
dc.titleChelating agents as potential antitumorals: alfa-(N)-heterocyclic hydrazones and bis-alfa-(N)-heterocyclic hydrazonesen_US
dc.typeArticleen_US
dc.identifier.pmid9507672en_US
dc.identifier.scopus2-s2.0-0031408049en_US
dc.identifier.isiWOS:000072086200006en_US
dc.relation.volume52en_US
dc.relation.issue10en_US
dc.description.firstpage609en_US
dc.description.lastpage613en_US
dc.description.thirdmissionNot applicableen_US
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeArticle-
item.fulltextNo Fulltext-
Appears in Collections:Publications
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.